TMO

SELL

Thermo Fisher Scientific Inc

Healthcare · Rank #257 · Analyzed Jul 13, 2026

$527.05

Current Price

$217.99

Intrinsic Value

-58.6%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 58.6%

Fair Value Range

Low$145.99

Base (IV)$217.99

High$290.25

Entry Points

Conservative$102.19

Moderate$145.99

Aggressive$152.59

Quality & Moat Breakdown

Return on Equity13.5% → 0.5/1.0

Debt LevelD/E 83 → 0/1.0

Revenue QualityGrowth 4.5%, margin Δ-1.0% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins15.2% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.